Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Feature
  • Published:

European exploitation of biotechnology—do government policies help?

Nature Biotechnology volume 18, pages 605–608 (2000)Cite this article

A recent survey of public spending on biotechnology in Europe suggests that money alone cannot stimulate growth of the sector.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1

References

  1. Enzing, C. et al. J. Inventory of public biotechnology R&D programmes in Europe, Analytical Report, vol 1. (Office for Official Publications of the European Communities, Luxembourg, 1999). Volumes 2 and 3, containing national reports, will be published in 2000.

    Google Scholar 

  2. Databases vary widely in their estimates of the number of French biotechnology firms. An emerging consensus indicates there are about 80–100.

  3. BioResearch Ireland. BioResearch Ireland review '97. Putting Ireland on the biotechnology map. (BRI, Dublin, Ireland, 1998).

Download references

Acknowledgements

The authors are grateful for support from the EC's BIOTECH programme, which funded this project through contracts BIO4-CT97-2089/2090/2091 and 2346.

Author information

Authors and Affiliations

  1. senior fellow at SPRU Science and Technology Policy Research, Mantell Building, University of Sussex, Brighton, BN1 9RF, UK

    Jacqueline Senker

  2. senior research fellow at TNO Strategy, Technology and Policy, PO Box 6030, JA Delft, 2600, The Netherlands

    Christien Enzing

  3. research director at SERD, Institut National de la Recherche Agronomique, Université Pierre Mendès France, BP 47, Grenoble, 38040 Cedex 9, France

    Pierre-Benoît Joly

  4. head of Innovations in Biotechnology Department at Fraunhofer Institute Systems and Innovation Research, Breslauer Strasse 48, Karlsruhe, D-76139, Germany

    Thomas Reiss

Authors
  1. Jacqueline Senker
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Christien Enzing
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Pierre-Benoît Joly
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Thomas Reiss
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Senker, J., Enzing, C., Joly, PB. et al. European exploitation of biotechnology—do government policies help?. Nat Biotechnol 18, 605–608 (2000). https://doi.org/10.1038/76439

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/76439

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing